Brief: Ac Immune To Present Progress Of Alzheimer’S Disease Programs Targeting Abeta And Tau At The 15Th Ctad Conference
23/11/2022 12:53
Nov 23 (Reuters) - AC Immune SA ACIU.O :
* AC IMMUNE TO PRESENT PROGRESS OF ALZHEIMER’S DISEASE
PROGRAMS
TARGETING ABETA AND TAU AT THE 15TH CTAD CONFERENCE
* AC IMMUNE SA - NEW DATA ON ANTI-PHOSPHO-TAU VACCINES
CONFIRM
SAFETY, TOLERABILITY AND IMMUNOGENICITY OF ACI-35 AND JACI-35
Source text for Eikon: ID:nGNXbMtxy4
Further company coverage: ACIU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture